Maxor announces the appointment of Kim Tzoumakas as new CEO and its strategic combination with ProxsysRx | PR Newswire [Video]

, /PRNewswire/ — Maxor National Pharmacy Services (“Maxor”), a leading pharmacy care solutions company, announced today that Kim Tzoumakas has been named the Company’s new Chief Executive Officer and has also been appointed to the Board of Directors, effective January 6, 2025. Ms. Tzoumakas succeeds Mike Ellis, who has retired as CEO and moved into the role of Chairman of the Board of Directors after successfully leading the company since 2016. 

Simultaneously, Maxor announced its strategic combination with ProxsysRx, further accelerating the growth of Maxor’s Pharmacy Services segment and positioning Maxor as the largest independent provider of pharmacy management services to health systems, hospitals, clinics, and other provider organizations.

Ms. Tzoumakas is a seasoned executive with more than 25 years of strategic and operational leadership experience within the healthcare sector. Most recently, Ms. Tzoumakas served as CEO of RAYUS Radiology, a leading national provider of advanced diagnostic and interventional radiology services. Ms. Tzoumakas has a proven track …